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ABSTRACT
Objectives: To determine whether postoperative
delirium predicts first-time readmissions and mortality in
octogenarian patients within 180 days after aortic valve
therapy with surgical aortic valve replacement (SAVR) or
transcatheter aortic valve implantation (TAVI), and to
determine the most common diagnoses at readmission.
Design: Prospective cohort study of patients undergoing
elective SAVR or TAVI.
Setting: Tertiary university hospital that performs all
SAVRs and TAVIs in Western Norway.
Participants: Patients 80+ years scheduled for SAVR or
TAVI and willing to participate in the study were eligible.
Those unable to speak Norwegian were excluded. Overall,
143 patients were included, and data from 136 are
presented.
Primary and secondary outcome measures: The
primary outcome was a composite variable of time from
discharge to first all-cause readmission or death.
Secondary outcomes were all-cause first readmission
alone and mortality within 180 days after discharge, and
the primary diagnosis at discharge from first-time
readmission. Delirium was assessed with the confusion
assessment method. First-time readmissions, diagnoses
and mortality were identified in hospital information
registries.
Results: Delirium was identified in 56% of patients.
The effect of delirium on readmissions and mortality was
greatest during the first 2 months after discharge
(adjusted HR 2.9 (95% CI 1.5 to 5.7)). Of 30 first-time
readmissions occurring within 30 days, 24 (80%) were
patients who experienced delirium. 1 patient (non-
delirium group) died within 30 days after therapy.
Delirious patients comprised 35 (64%) of 55 first-time
readmissions occurring within 180 days. Circulatory
system diseases and injuries were common causes of
first-time readmissions within 180 days in delirious
patients. 8 patients died 180 days after the procedure;
6 (75%) of them experienced delirium.
Conclusions: Delirium in octogenarians after aortic
valve therapy might be a serious risk factor for
postoperative morbidity and mortality. Cardiovascular
disorders and injuries were associated with first-time
readmissions in these patients.
INTRODUCTION
Surgical aortic valve replacement (SAVR)
and transcatheter aortic valve implantation
(TAVI) have resulted in successful outcomes,
even in very old patients.1–4 An increasing
number of older cardiovascular patients
expect improvements in physical function
and independence, without compromising
longevity.5 6 However, there are trade-offs in
performing surgery in older patients that
works against these goals. The effect delir-
ium has on short-term and long-term mor-
bidity and mortality in octogenarian patients
undergoing SAVR or TAVI is of interest to
clinicians who refer and treat these patients,
and also to healthcare providers aiming to
improve quality of hospital care.7
Strengths and limitations of this study
▪ This is the first study that systematically evalu-
ates delirium for 5 postoperative days, focusing
exclusively in octogenarian patients undergoing
aortic valve therapy with surgical aortic valve
replacement (SAVR) or transcatheter aortic valve
implantation (TAVI), and aiming to establish
whether delirium predicts first-time readmissions
and mortality within 180 days after hospital
discharge.
▪ The high rate of inclusion in this study ensures
that the data are representative of octogenarians
with severe aortic stenosis referred for SAVR or
TAVI and makes our results comparable to other
studies that sampled more populated areas.
▪ Data are limited to a tertiary university hospital.
▪ This study concentrates in the time period within
180 days after hospital discharge after aortic
valve therapy with SAVR or TAVI, and longer
follow-up periods might be necessary to address
other consequences of delirium in this patient
group.
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Delirium is an acute and fluctuating change in atten-
tion and cognition that increases the risk for functional
decline, institutionalisation and death in hospitalised
older patients.8 The incidence of delirium in octogenar-
ians after aortic valve therapy can be as high as 56%.9
Yet, it is less likely to occur in patients undergoing the
less invasive TAVI than in those receiving SAVR,9 even
though TAVI patients are usually older, have more
advanced left ventricular dysfunction and often have
several comorbidities.2
The relationship between delirium, cardiac surgery
and undesirable events such as hospital readmissions
and mortality has previously been studied.10 11 However,
to the best of our knowledge, the role that delirium
plays in these outcomes in the oldest group of patients
after receiving SAVR or TAVI remains to be established.
Little is known also about the causes of short-term and
long-term readmissions in this patient cohort.
Therefore, the aim of this study was to (1) determine
whether the presence of postoperative delirium can
predict the risk of first-time readmissions and mortality
in octogenarian patients within 180 days after SAVR or
TAVI, and (2) to identify causes of these first-time read-
missions (ie, discharge diagnoses) in patients who had
delirium. We hypothesised that delirium leads to higher
rates of readmission and mortality.
METHODS
Design and setting
We conducted a prospective cohort study of consecu-
tively admitted octogenarian patients treated for severe
aortic stenosis (AS) with SAVR or TAVI. The study was
performed in a tertiary university hospital in Norway.
This hospital is responsible for performing SAVR and
TAVI procedures for the entire western region of
Norway, which comprises more than 1 300 000 inhabi-
tants.12 Follow-up was performed 30 and 180 days after
hospital discharge.
Study population
Participants were recruited into the larger ‘Delirium in
octogenarians undergoing cardiac surgery or interven-
tion (CARDELIR)’ study.9 Inclusion criteria were age of
80 years or older and previous acceptance for elective
AS treatment with SAVR or TAVI. Exclusion criteria were
patients’ declined consent to join the study or inability
to speak Norwegian. The primary end point of
CARDELIR was the presence of postoperative delirium.
Prior to inclusion, a heart team, consisting of cardio-
thoracic surgeons and invasive cardiologists, assessed the
severity of AS13 and identified patients ineligible for
SAVR. Reasons for disqualifying patients for traditional
aortic valve replacements were previous coronary artery
bypass graft, severe respiratory insufficiency, comorbid-
ities that could compromise recovery and prior thoracic
radiotherapy. Between February 2011 and August 2013,
162 octogenarians received elective AS treatment. Of
these, 15 did not fulfil the inclusion criteria, and 3
patients failed to be identified prior to treatment due to
administrative reasons. A total of 144 patients agreed to
participate. The data of 136 of these are presented in
this study. One of the 144 withdrew consent prior to
treatment, and for 7 patients delirium could not be
assessed, because they were non-responsive after surgery
or had died (figure 1). TAVI was performed in 63
patients (46%). Patients were classified as delirious if
delirium was objectively identified on at least 1 of the 5
postoperative days. Some patients were not assessed for
the presence of delirium on each day due to administra-
tive or other reasons not related to the study, and thus
were classified according to their delirium status for the
days they were assessed.14
MEASUREMENTS
Delirium
The presence of delirium was established with the confu-
sion assessment method (CAM).15 CAM is based on
nine operationalised criteria from the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV), and four
Figure 1 Flow chart of included patients.
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features: (1) acute onset and fluctuating course, (2)
inattention, (3) disorganised thinking and (4) altered
level of consciousness. Delirium is diagnosed when fea-
tures 1 and 2 are present, and either 3 or 4 are dis-
played. CAM is a valid and reliable instrument.16
Patients’ general characteristics, health and comorbidities
The Mini-Mental State Examination (MMSE) was used
to assess general preoperative cognitive function.17 The
MMSE uses an assessment scale from 0 to 30, in which
low scores represent lower levels of functioning.17 18
The Barthel index19 was used to assess patients’ basic
self-care abilities. The total score on the scale ranges
from 0 to 20, with high scores indicating higher levels of
independence.19–21
We used the Nottingham Extended Activities of Daily
Living Scale (ADL) to evaluate the patients’ ability to
perform tasks reflecting complex levels of functioning.22
The highest score on the scale is 66, representing a high
level of independence.22 23
We established the burden of comorbidity with the
Charlson comorbidity index (CCI). This instrument pre-
dicts 10-year mortality by assigning values to different
comorbid conditions.24 25
Cardiac operative risk was evaluated with the Logistic
European System for Cardiac Operative Risk Evaluation
I (Logistic EuroSCORE I).26 The logistic EuroSCORE I
predicts operative mortality using 17 risk variables, and
high scores reflect a higher risk for mortality.27
Data collection
Baseline data and postoperative assessment of delirium
A description of data collection at baseline and the
assessment of postoperative delirium were presented pre-
viously.9 Briefly, patients fulfilling the inclusion criteria
were identified and approached the day before surgery.
The study was explained and participants gave informed
consent to enrolment before data collection started.
Delirium was assessed by the first author and by
members of the research team trained in the use of
CAM. These members have their clinical practice at the
Department of Heart Disease and they participated in
information meetings regarding delirium given to
healthcare providers in our department. They also
received one-on-one sessions that covered more exten-
sive knowledge regarding delirium, that included several
examples about its features and that explained the use
of CAM. Assessment of delirium was performed daily, at
noon, from postoperative day 1 to day 5, including week-
ends. Medical, nursing and physiotherapists’ reports
from the previous 24 hours were also considered when
CAM was scored.
Follow-up at 30 and 180 days
The hospital information registry provided information
required to identify first-time readmission and discharge
diagnoses in accordance with the International Statistical
Classification of Diseases and Related Health Problems, 10th
Revision (ICD-10).28 The registry also helped to identify
time of death for deceased patients who had been
assessed for delirium earlier.
Study outcomes
The primary outcome was a composite variable of time
from discharge to first all-cause readmission or death,
from hospital discharge to 30 and 180 days after dis-
charge. Secondary outcomes were all-cause first readmis-
sion alone and mortality 30 and 180 days after
discharge, and the primary diagnosis at discharge from
first-time readmission.
Other study variables
Gender, age, baseline MMSE scores and comorbidity
(CCI), as well as type of therapy (SAVR and TAVI) as
confounders, were selected based on guidance from pre-
vious literature29 30 and clinical experience.
Statistical analysis
Data are presented as counts and percentages, or means
and SDs. Differences between groups at baseline were
tested with the χ2 test for categorical variables and the
t-test for continuous variables. The Kaplan-Meier survival
curves and an exact Gehan-Breslow test stratified by type
of aortic valve therapy were used to examine and test for
differences in time to readmission/death. The
Gehan-Breslow test was chosen because it places greater
weight on early events. The exact conditional distribu-
tion of the test statistic was evaluated using a Monte
Carlo procedure with 100 000 replications, using the R
package ‘coin’31 V.1.1-2. The Cox proportional hazard
regression analyses stratified by therapy type (SAVR/
TAVI) were used to adjust for gender, age (as a non-
linear/quadratic effect), MMSE and comorbidities.
Statistical analyses were performed using IBM SPSS for
Windows, V.22.0 (IBM SPSS Statistics for Windows
[program]. 22.0 version. Armonk, NY: IBM Corp, 2013)
and R V.3.2.3 (R Foundation for Statistical Computing,
Vienna, Austria) (R Core Team. R: a language and envir-
onment for statistical computing. Secondary R: a lan-
guage and environment for statistical computing. 2015.
https://www.R-project.org/). A two-tailed p value of
≤0.05 was considered statistically significant.
Ethical considerations
Research involving older patients requires special consid-
eration with respect to functional disabilities and
complex health conditions. Therefore, data collection
was performed by members of the research team with
extensive experience with geriatric and cardiac patients.
Special attention was paid to signs of distress or fatigue,
and data collection was stopped when such signs were
present.
In order to guarantee confidentiality, independent
access to information regarding first-time readmission
from each of the five referring hospitals the patients
belonged to had to be obtained.
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Patient involvement
No patients were involved in the design and implemen-
tation of the study. However, patient self-report is at the
very core of the CARDELIR study.9 14 32 33 Also, 10
patients participated in qualitative interviews to describe
their experiences with delirium.34 There are plans to dis-
seminate the results of the research to the patient com-
munity through patient organisations.
RESULTS
Baseline characteristics and postoperative delirium
Table 1 shows the overall baseline characteristics of
included patients (n=136). Table 2 presents character-
istics of patients assessed for delirium, according to read-
missions or death 30 and 180 days after discharge from
SAVR or TAVI. Compared with patients treated with
SAVR, octogenarian patients undergoing TAVI were
older (82.3 vs 84.8 years, p<0.001); had lower MMSE
scores (26.5 vs 27.8, p=0.009); greater number of
comorbidities (2.4 vs 1.8, p=0.001); higher logistic
EuroSCORE (19.6 vs 9.4, p<0.001) and more often had
American Society of Anesthesiologist physical status clas-
sification system (ASA) scores of IV (21 vs 2, p<0.001).
No differences in gender (63% female vs 51% male,
p=0.11) or in the performance of ADL (18.8 vs 19.0,
p=0.31) were found between the SAVR and TAVI groups.
Of the 136 patients assessed, 56% developed delirium.
Delirium was identified in 44% of patients treated with
TAVI and in 66% of those receiving SAVR (p=0.01). The
average number of days with delirium for patients
treated with SAVR was 1.5 days and for patients treated
with TAVI, 1.1 days (p=0.20). A table showing living
environment within 30 and 180 days after open surgery
or transcatheter intervention is presented in online
supplementary appendix 1.
Readmissions and mortality
Figure 2 presents the proportions of types of discharge
diagnoses following first-time readmission, 30 and
180 days after therapy with SAVR or TAVI, according to
the ICD-10, and stratified by the presence/absence of
delirium.
Readmissions and mortality within 30 days after discharge
Of the 30 patients (22%) readmitted for the first time
within 30 days after SAVR or TAVI, 24 (80%) had delir-
ium. The majority of readmitted patients in the delirium
group returned to the hospital for cardiovascular disor-
ders with no dominant-specific diagnoses, and only two
patients returned because of heart failure. Eight per
cent of the readmitted patients in the delirium group
exhibited symptoms such as chest pain and dyspnoea,
and had contact with health services, whereas 4% of the
readmitted patients were hospitalised for external injur-
ies such as fall injuries.
Cardiovascular disorders were causes of first-time
readmission in two of the non-delirious patients and
another two were readmitted due to pneumonia. One
patient in the non-delirious group died within 30 days
after discharge.
Readmissions and mortality within 180 days of discharge
Of the 58 patients readmitted for the first-time within
180 days after aortic valve therapy, 37 (64%) were in the
group that had delirium. Readmission diagnoses for
patients who had delirium covered a wide variety of
ICD-10 categories, with diagnoses related to the circula-
tory system being the most common (13%). Heart
failure was identified in 4% of first-time readmissions,
and complications after cardiac surgery in 3%.
Additional readmissions were related to pulmonary
hypertension and embolism, other heart diseases and
myocardial infarction. Fall injuries or other complica-
tions resulted in 5% of first-time readmissions.
In patients without delirium, diseases of the circula-
tory system were responsible for 15% of first-time read-
missions. Heart failure and arrhythmias were the most
common. Three patients (5%) were readmitted because
of injuries like bone fractures, and three had pneumo-
nia. Six out of eight patients who died within 180 days
after aortic valve therapy had postoperative delirium.
Survival analyses
Figure 3 shows survival curves for 30-day and 180-day
readmissions and mortality according to delirium and
type of aortic valve therapy. After stratifying for type of









Barthel index 18.9 ±1.4
Nottingham IADL 54.2 ±10.1
BMI (kg/m2) 25.5 ±4.2
Charlson comorbidity index 2.1 ±1.2
Logistic EuroScore 14.0 (9.2)
NYHA function class I+II 47 (35)
NYHA function class III+IV 75 (55)
Left ventricle ejection fraction (%) 56.6 ±10.2
Max aorta gradient (mm Hg) 79.5 ±23.9
Mean aorta gradient (mm Hg) 48.3 ±16.1
Aortic valve area (cm2/m2) 0.4 ±0.2
Preoperative atrial fibrillation 39 (27)
ASA classification III 114 (84)
ASA classification IV 22 (16)
Treatment: TAVI 65 (45)
Delirium (yes) 76 (56)
ASA, American Society of Anesthesiologist physical status
classification system; BMI, body mass index; IADL, instrumental
activities of daily living; MMSE, Mini-Mental State Examination;
NYHA, New York Heart Association Functional Classification;
TAVI, transcatheter aortic valve implantation.
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therapy (SAVR vs TAVI), differences were revealed in
time to readmission and mortality between patients with
and without delirium within 180 days after discharge
(p=0.02). These differences were already present 30 days
after discharge (p=0.006).
Initial analyses revealed that the effect of delirium was
not well described by the Cox proportional hazard
model (p=0.03 in a test for the proportional hazard
assumption). Examination of Schoenfeld residuals indi-
cated that the effect of delirium on hazard diminished
over time, and this was particularly pronounced starting
about 60 days after initial discharge. We therefore fitted
a model using a factor for a time-dependent effect of
delirium, in which the effect was constant up to 60 days
(ie, assuming proportional hazards up to this time
point) and then linear with time from 60 to 180 days
Table 2 Characteristics of patients assessed for delirium, according to readmissions or death 30 and 180 days after
discharge from surgical aortic valve replacement or transcatheter aortic valve implantation (n=136)



























Age (years) 83.3 2.7 83.9 2.6 0.29 83.5 2.7 83.3 2.6 0.66
Women 62 (59) 14 (45) 0.17 46 (59) 30 (52) 0.40
Married 55 (52) 18 (58) 0.58 43 (55) 30 (52) 0.69
MMSE 27.1 3.0 27.5 2.8 0.49 27.2 3.1 27.3 2.7 0.74
Barthel index 19.1 1.3 18.4 1.8 0.05 19.3 1.1 18.5 1.7 0.002
Nottingham IADL 54.7 9.5 52.7 11.9 0.44 56 9.3 51.7 10.8 0.03
BMI (kg/m2) 25.4 4.4 25.7 3.5 0.68 25.7 4.4 25.2 3.9 0.44
Charlson comorbidity
index
2.03 1.1 2.3 1.2 0.25 1.9 1.1 2.3 1.2 0.09
Logistic EuroScore 13.4 8.1 16.1 12 0.24 13.1 8.3 15.1 10.3 0.24
NYHA function class 0.28 0.02
I+II 39 (41) 8 (30) 33 (47) 14 (27)
III+IV 56 (59) 19 (70) 37 (53) 38 (73)
LVEF (%) 57.7 9.6 52.8 11.5 0.04 57.9 9.6 54.7 10.8 0.07
Maximum aorta
gradient (mm Hg)
80.6 24.7 75.5 20.6 0.27 78.3 22.8 81.1 25.5 0.51
Mean aorta gradient
(mm Hg)
49.3 16.7 45 13.6 0.15 47.7 15.5 48.9 16.9 0.7
Aortic valve area
(cm2/m2)
0.38 0.11 0.44 0.28 0.3 0.4 0.11 0.40 0.22 0.9
ASA classification 0.27 0.22
III 90 (86) 24 (77) 68 (87) 46 (79)
IV 15 (14) 7 (23) 10 (13) 12 (21)
Treatment: TAVI 50 (48) 13 (42) 0.58 35 (45) 28 (48) 0.69
ASA, American Society of Anesthesiologists physical status classification system; BMI, body mass index; IADL, instrumental activities of daily
living; LVEF, left ventricle ejection fraction; MMSE, Mini-Mental State Examination; NYHA, New York Heart Association Functional
Classification.
Figure 2 Proportions of discharge diagnoses or death following first readmission/death within 30 or 180 days after initial
discharge, according to the presence of delirium and in accordance with the International Statistical Classification of Diseases
and Related Health Problems, 10th Revision (ICD-10).
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(table 3). This greatly improved the model fit, and a test
of model assumptions no longer indicated any lack of
fit. The HR up to 60 days was estimated to be 2.9 (95%
CI 1.5 to 5.7). The effect was reduced over time (an esti-
mated reduction of about 3% for each day after the 60th
day), but there is great uncertainty in these estimates,
due to a low number of later events. For example, there
were only six events between 120 and 180 days, making
it impossible to obtain reliable estimates for the shape of
the time-dependent HR for this period. Additional com-
pletely stratified analyses did not find any effect modifi-
cation (results not reported).
DISCUSSION
This prospective study shows that delirium is a serious
postoperative complication that predicts first-time read-
missions and death in octogenarian patients who have
had SAVR or TAVI therapy. The number of first-time
readmissions or deaths within 180 days after SAVR or
TAVI was considerably higher for patients who experi-
enced delirium, and this difference was especially pro-
nounced within 30 days after therapy. The most
common cause of first-time readmission in all included
patients was related to heart failure; injuries and infec-
tions also were frequent diagnoses. In octogenarians
who experienced delirium, reasons for first-time
readmission covered all general diagnostic categories of
the ICD-10, and included symptoms lacking specific
pathology and contact with health services without a spe-
cific diagnosis. In the group not experiencing delirium,
first-time readmissions were most often related to disor-
ders of the circulatory system. Mortality was higher in
the group of patients who experienced delirium.
Despite originating from a single centre, this study
includes data on the entire western region of Norway,
which has a population of more than 1300 00035 and
covers the total population of five other regional hospi-
tals. Health services in Norway provide equal access to
free hospital treatment, medication and hospital accom-
modation to everyone who is part of the National
Insurance Scheme. Advanced treatments, such as SAVR
and TAVI, are performed only in specialised hospitals
like ours. The high rate of inclusion in this study
ensures that the data are representative of octogenarians
with severe AS referred for SAVR or TAVI in Norway and
in other industrialised countries with a similar health
system. This makes our results comparable to other
Figure 3 Kaplan-Meier survival
curves for first-time readmission
or death, stratified by
postoperative delirium and
treatment procedure with surgical
aortic valve replacement (SAVR)
or transcatheter aortic valve
implantation (TAVI).
Table 3 Cox regression model (with time-dependent effect of delirium) for time to first readmission/death within 180 days
after initial discharge from hospital (n=136)
HR 95% CI p Value
Treatment* – – –
Gender (female) 0.76 0.44 to 1.31 0.33
Age (linear and non-linear effects) – – 0.99
Charlson comorbidity index 1.25 1.00 to 1.57 0.06
MMSE 1.03 0.94 to 1.13 0.48
Delirium 2.93 1.51 to 5.67 0.002
Delirium×(no. of days after 60) 0.97 0.94 to 0.99 0.02
*Treatment (TAVI vs SAVR) was included as a stratification variable.
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studies that sampled from more populated areas.29 30
Octogenarian patients are increasingly being recipients
of advanced treatments such as SAVR and TAVI, and our
results may also be applied in other settings where
advanced treatment is offered to the elderly.
Previous research has provided important information
regarding the survival of patients treated with SAVR or
TAVI.36–38 The primary outcome of these studies was sur-
vival 1,38 236 and 5 years37 after the procedure. However,
older patients seeking this therapy expect that it will not
only increase their longevity, but also will reduce disabil-
ity and help them avoid further hospitalisations.39 These
expectations are at variance with our previous findings.
We showed that patients treated with TAVI and who had
postoperative delirium experienced significant decreases
in ADL and IADL functions 1-month after therapy.14
A recent study also showed an association between phys-
ical impairment and 30 days all-cause hospital readmis-
sion.40 Moreover, in the present study, patients with
delirium had a much higher rate of all-cause readmis-
sions and death 30 days after discharge than those
without delirium, regardless of the type of AS therapy.
These results may suggest that patients at risk for devel-
oping delirium are more vulnerable at baseline and con-
tinue to be vulnerable at hospital discharge, hence
explaining the higher risk for later hospitalisations and
death. This highlights the effect that delirium may have
in this patient group.
Our results can be compared with those of a previous
study on 30-day readmissions among patients treated
with SAVR or TAVI.30 This study did not find significant
differences in 30-day readmissions between therapy
types. However, the study differed from ours in that it
focused on readmissions as a function of therapy type
only, and did not take delirium status into consideration.
A recently published study examining 1-year mortality in
SAVR and TAVI patients according to the presence or
absence of delirium found a positive association
between the presence of delirium and morbidity and
mortality,41 a finding that is consistent with our results.
However, their study differed in that its assessment was
limited to the initial stay in the intensive care unit, used
a retrospective design and did not assess readmissions
and mortality within the first 6 months after discharge.
Our study provides important new evidence showing
that postoperative delirium is an undesirable outcome in
older patients, especially octogenarians, undergoing
treatment for AS. A previous study found a lower inci-
dence of delirium after TAVI compared with SAVR.9
However, the short-term and long-term consequences of
delirium for TAVI patients emphasise the need to imple-
ment strategies early on to reduce its development and
also to possibly develop a specific TAVI risk score.42
Strong evidence supports multicomponent interventions
to prevent delirium in hospitalised patients,43 and our
results suggest that such interventions should be imple-
mented in hospital settings where SAVR and TAVI are
offered, especially since these procedures are often
performed on older people. Knowledge about how delir-
ium affects first-time readmissions and mortality follow-
ing aortic valve therapy might facilitate clinical
decision-making and dialogue between patients and phy-
sicians when deciding a treatment path. Better clinical
tools to predict which patients are at risk to develop post-
operative delirium are also warranted, as these tools
would identify at-risk patients who should receive either
medical treatment or undergo the least invasive surgical
modality.
There are several strengths to our study, including its
prospective design and the use of a valid and reliable
instrument to assess delirium for 5 postoperative days.
The tertiary university hospital in which data were col-
lected and the low number of patients who refused par-
ticipation (6%) provides the possibility of generalisation
not only in terms of the western part of Norway, but also
to other western populations where SAVR and TAVI are
offered to octogenarian patients. An additional strength
is found in the fact that patient’s readmissions were com-
pletely blinded for the research team.
The lack of randomisation is a limitation. However,
since SAVR and TAVI were offered different treatment
groups with regard to surgical risk factors, a randomised
design was not possible.2 The modest sample size has
also limited the possibility of more analyses. Another
limitation of our study lies in the lack of inter-rater reli-
ability measurement. Even though the majority of assess-
ments for delirium were performed by the first author,
there were cases (ie, some weekends and holydays)
where other members of the research team were respon-
sible for using the CAM.
It remains to be established whether delirium is caus-
ally related to the higher number of readmissions and
deaths 30 and 180 days after discharge, or whether
patients with several readmissions are already more vul-
nerable before aortic valve therapy, and therefore more
prone to develop delirium. Future research should
address the consequences of delirium in this patient
group using a longer follow-up period.
CONCLUSIONS
First-time hospital readmissions and mortality within 30
and 180 days after hospital discharge were more often
present in octogenarian patients who had postoperative
delirium after SAVR or TAVI therapy. Our results suggest
that delirium may be a serious risk factor for negative
events leading to readmissions and death in octogenar-
ian patients treated with SAVR for severe AS, and even
for those treated with the less invasive TAVI therapy.
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